The new crown drug "Dipyridamole" screened by Tianhe supercomputer has significant initial clinical effects!

CCTV News Client Headquarters reporters learned from the National Supercomputing Center in Tianjin that on November 4, the American Association for Computing Machinery (ACM) announced that the National Supercomputing Center in Tianjin, the School of Computer Science, United Nations Defense Technology University, the School of Pharmacy, Hainan University, and the School of Pharmacy, Sun Yat-sen University The “Large-scale Virtual Screening of New Coronary Drugs Based on Free Energy Perturbation-Absolute Free Energy Method” completed on Tianhe’s new-generation supercomputers, Ocean University of China School of Medicine, University of Kentucky School of Pharmacy, etc.

This result was nominated and recommended by Academician Chen Kaixian of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Professor Qian Depei of Beihang University, and Professor Hans Westerhoff of University of Amsterdam in the Netherlands

The Gordon Bell Prize is the highest academic award in the field of high-performance computing applications in the world.

Editor in charge: Wang Fa

Dipyridamole (Dipyridamole) is a coronary artery dilation and anti-thrombosis drug.

Arbidol is a non-nucleoside broad-spectrum antiviral drug with immuno-enhancing effect, used to treat upper respiratory tract infections caused by influenza A and B viruses

Source: Baidu Encyclopedia